Fermenta Biotech shares make debut on NSE
The company said the listing marks a milestone in Fermenta’s 75-year journey
Fermenta Biotech Ltd, a global manufacturer of the active pharmaceutical ingredient in Vitamin D3, has successfully listed its equity shares on the National Stock Exchange of India Ltd (NSE). This marks a significant milestone in the company's 75-year history, as it commemorates its 75th anniversary while remaining a publicly listed enterprise.
Fermenta's shares, with a face value of ₹5, have been listed, and the company has confirmed that its shares will also continue to be listed on the Bombay Stock Exchange (BSE). The NSE listing underscores Fermenta's growth trajectory, expanding global customer base, and increasing investor interest.
Brief written by urgent.news from Hindu BusinessLine's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
